NCT06171568

Brief Summary

Cognitive sequelae are common following acquired brain injuries. However, their detection can be challenging, particularly in acute care units such as neurosurgery. Specific screening in acute phase is critical for early detection and proper orientation. The Lariboisière cognitive assessment (Cog-First) is a brief cognitive evaluation conducted on a touch-screen tablet for patients with acquired brain injuries in the acute phase, which is integrated into routine care in Lariboisière. The objective of this project is to evaluate the one-year cognitive and functional outcomes of patients who have undergone hospitalization in neuro-surgery. The primary aim is to assess whether the systematic pre-discharge assessment (Cog-First) performed as part of routine care can predict a poor functional prognosis and help identify at-risk patients earlier and more effectively.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 14, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

March 22, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

May 31, 2024

Status Verified

May 1, 2024

Enrollment Period

11 months

First QC Date

December 6, 2023

Last Update Submit

May 29, 2024

Conditions

Keywords

Brain injuriesPrognosisCognitive impairmentCognitionExecutive FunctionNeuropsychological testsNeuro-rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Evaluation of the functional outcome at 1 year of patients who were hospitalized in the Lariboisière neurosurgery department compared with the initial systematic cognitive assessment (Cog-First)

    The Modified Rankin Scale (MRS) will be used during the systematic follow-up consultation. The MRS is a score allowing functional independence level notation from 0 (no symptoms or incapacity) to 5 (severe disability).

    1 year

Secondary Outcomes (7)

  • Assessment of the independence of patients in their daily life.

    1 year

  • Mesure of different cognitive functions of patients (language, memory, visio-spatial functions, attention, concentration, orientation in time and space).

    1 year

  • Assess various cognitive functions in patients, including language, memory and visio-spatial abilities

    1 year

  • Rivermead questionnaire

    1 year after discharge from Neurosurgery department of Lariboisière

  • Short Form (36) Health Survey (SF-36)

    1 year after discharge from Neurosurgery department of Lariboisière

  • +2 more secondary outcomes

Interventions

1 year after discharge from neurosurgery department, included patients will answer to the: * Modified Rankin Scale; * Instrumental Activities of Daily Living (IADL) questionnaire; * Montreal Cognitive Assessment (MoCA); * Frontal assessment battery (BREF); * Rivermead questionnaire; * Short Form (36) Health Survey (SF-36) * Community Integration Questionnaire - Revised (CIQ-R) * Posttraumatic stress disorder CheckList (PCL-5)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients hospitalized at Lariboisière hospital in neurosurgery unit between February 2023 and February 2024.

You may qualify if:

  • Patient over 18 years of age
  • Patient hospitalized in neurosurgery unit at Lariboisière hospital between February 2023 and February 2024
  • Patient discharged home
  • Patient affiliated to the social security system
  • Patient having expressed no opposition

You may not qualify if:

  • Patient transferred to a rehabilitation facility following hospitalization in neurosurgery
  • History of neurological or psychiatric illness
  • Severe uncorrected visual impairment and/or aphasia
  • Non-French-speaking patients
  • Patients receiving State Medical Aid (AME)
  • Patients under guardianship/curatorship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neurosurgery - Lariboisière hospital

Paris, Île-de-France Region, 75010, France

RECRUITING

Related Publications (8)

  • Peeters W, van den Brande R, Polinder S, Brazinova A, Steyerberg EW, Lingsma HF, Maas AI. Epidemiology of traumatic brain injury in Europe. Acta Neurochir (Wien). 2015 Oct;157(10):1683-96. doi: 10.1007/s00701-015-2512-7. Epub 2015 Aug 14.

    PMID: 26269030BACKGROUND
  • Jourdan C, Azouvi P, Genet F, Selly N, Josseran L, Schnitzler A. Disability and Health Consequences of Traumatic Brain Injury: National Prevalence. Am J Phys Med Rehabil. 2018 May;97(5):323-331. doi: 10.1097/PHM.0000000000000848.

    PMID: 29016402BACKGROUND
  • Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil. 2006 Sep-Oct;21(5):375-8. doi: 10.1097/00001199-200609000-00001.

    PMID: 16983222BACKGROUND
  • Stocchetti N, Zanier ER. Chronic impact of traumatic brain injury on outcome and quality of life: a narrative review. Crit Care. 2016 Jun 21;20(1):148. doi: 10.1186/s13054-016-1318-1.

    PMID: 27323708BACKGROUND
  • Jourdan C, Bayen E, Bosserelle V, Azerad S, Genet F, Fermanian C, Aegerter P, Pradat-Diehl P, Weiss JJ, Azouvi P; Members of the Steering Committee of the PariS-TBI Study. Referral to rehabilitation after severe traumatic brain injury: results from the PariS-TBI Study. Neurorehabil Neural Repair. 2013 Jan;27(1):35-44. doi: 10.1177/1545968312440744. Epub 2012 Mar 28.

    PMID: 22460612BACKGROUND
  • Schnitzler A, Erbault M, Solomiac A, Sainte Croix D, Fouchard A, May-Michelangeli L, Grenier C. Early rehabilitation after stroke: Strong recommendations but no achievement in the French Acute Healthcare Facilities. Ann Phys Rehabil Med. 2019 Jan;62(1):58-59. doi: 10.1016/j.rehab.2018.07.001. Epub 2018 Jul 19. No abstract available.

    PMID: 30031892BACKGROUND
  • Rodrigues JC, Becker N, Beckenkamp CL, Mina CS, de Salles JF, Bandeira DR. Psychometric properties of cognitive screening for patients with cerebrovascular diseases A systematic review. Dement Neuropsychol. 2019 Jan-Mar;13(1):31-43. doi: 10.1590/1980-57642018dn13-010004.

    PMID: 31073378BACKGROUND
  • de Guise E, Leblanc J, Champoux MC, Couturier C, Alturki AY, Lamoureux J, Desjardins M, Marcoux J, Maleki M, Feyz M. The mini-mental state examination and the Montreal Cognitive Assessment after traumatic brain injury: an early predictive study. Brain Inj. 2013;27(12):1428-34. doi: 10.3109/02699052.2013.835867. Epub 2013 Oct 8.

    PMID: 24102622BACKGROUND

MeSH Terms

Conditions

Brain InjuriesCognitive Dysfunction

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesCognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Emmanuel Mandonnet, MD, PhD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR
  • Alexis Schnitzler, MD, PhD

    Assistance Publique - Hôpitaux de Paris

    STUDY DIRECTOR

Central Study Contacts

Camille Heslot, MD

CONTACT

Alexis Schnitzler, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2023

First Posted

December 14, 2023

Study Start

March 22, 2024

Primary Completion

March 1, 2025

Study Completion

March 1, 2025

Last Updated

May 31, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations